Schwind PresbyMAX treats presbyopia with excimer surgery

Article

Schwind unveiled its PresbyMAX software module at ESCRS, a presbyopia solution for its AMARIS system. According to Schwind, the software makes it possible, for the first time, to treat emmetropic as well as myopic, hyperopic and astigmatic patients whose accommodative response is limited.

Schwind unveiled its PresbyMAX software module at ESCRS, a presbyopia solution for its AMARIS system. According to Schwind, the software makes it possible, for the first time, to treat emmetropic as well as myopic, hyperopic and astigmatic patients whose accommodative response is limited.

In contrast to other methods of treating presbyopia, PresbyMAX delivers bi-aspheric multifocal ablation profiles. Bi-aspheric refers to aspheric optimisation of the central corneal area for near vision and the midperipheral cornea for far vision of each patient eye. Near vision of presbyopic patients, even with additional visual defects like distance refraction and high-order aberrations, is significantly improved, providing sharper vision without the need for spectacles.

The software was developed by Schwind in cooperation with VISSUM under the direction of editorial advisory board member, Prof. Jorge Alio, Spain, and the OCIVIS group from the University of Alicante. He said: “The central development goal of PresbyMAX was to provide the first systematic and scientifically based approach for the correction of presbyopia with excimer laser surgery.”

Similar to multifocal contact lenses or refractive multifocal IOLs, PresbyMAX creates a multifocal corneal surface. Bi-aspheric multifocal ablation profiles are optimised using a predictive model based on a light propagation algorithm.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.